Buy SS31 — Research-Grade Elamipretide | Real Peptides

Buy SS31 — Research-Grade Elamipretide | Real Peptides

Research published in the Journal of Cardiovascular Pharmacology found that SS31 (Elamipretide) reduced myocardial infarct size by up to 40% in animal models. Not through antioxidant scavenging, but by directly preventing cristae remodeling in damaged mitochondria. That's a fundamentally different mechanism from every other cardioprotective agent currently studied.

We've worked with research institutions across multiple continents studying mitochondrial dysfunction, and the single most common question we receive isn't about dosage or reconstitution. It's about peptide purity and whether the compound arriving in the lab is actually what the certificate of analysis claims it is.

What is SS31 and why do researchers buy SS31 for mitochondrial studies?

SS31, also known as Elamipretide or MTP-131, is a tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) that selectively targets the inner mitochondrial membrane where it binds to cardiolipin. The phospholipid that anchors complexes I, III, and IV of the electron transport chain. By stabilizing cardiolipin, SS31 prevents cristae remodeling, reduces reactive oxygen species production at the source, and preserves ATP synthesis capacity even under oxidative stress. Research institutions buy SS31 to study age-related mitochondrial decline, ischemia-reperfusion injury, heart failure models, skeletal muscle atrophy, and neurodegenerative conditions where mitochondrial dysfunction is a primary driver rather than a secondary consequence.

The distinction matters because most "mitochondrial support" compounds work downstream. Scavenging free radicals after they've already been produced, or providing substrate for ATP synthesis. SS31 works upstream, at the site where electron transport chain inefficiency begins. That's why it's being studied in clinical trials for conditions like primary mitochondrial myopathy and Barth syndrome, where the defect is structural, not substrate-limited.

This article covers what makes SS31 mechanistically unique, how to evaluate peptide purity before purchase, what reconstitution and storage protocols preserve peptide integrity, and what researchers need to verify in a certificate of analysis that most suppliers hope you won't check.

Why Researchers Buy SS31 for Mitochondrial Dysfunction Studies

Mitochondrial dysfunction is implicated in everything from age-related sarcopenia to neurodegenerative disease, but the challenge is that most interventions target secondary consequences. Oxidative damage, inflammation, ATP depletion. Rather than the structural changes that cause those downstream effects. SS31 is one of the few research compounds that addresses the root cause: cardiolipin instability and cristae remodeling.

Cardiolipin is a unique phospholipid found almost exclusively in the inner mitochondrial membrane, where it serves as a structural anchor for electron transport chain complexes. When cardiolipin oxidizes or dissociates from those complexes. Which happens during ischemia, oxidative stress, aging, and metabolic disease. Cristae structure collapses, electron transport becomes inefficient, and reactive oxygen species production increases exponentially. This creates a self-reinforcing cycle: ROS damages cardiolipin, damaged cardiolipin produces more ROS.

SS31 binds selectively to cardiolipin and prevents this cascade. Studies using isolated mitochondria demonstrate that SS31 reduces ROS production by up to 50% without acting as a traditional antioxidant. It doesn't scavenge free radicals; it prevents their formation by stabilizing electron flow. A 2013 study published in the British Journal of Pharmacology showed that SS31 preserved mitochondrial respiration in cardiomyocytes subjected to hypoxia-reoxygenation injury, maintaining complex I activity at near-baseline levels when untreated controls dropped by more than 60%.

Research institutions buy SS31 to study ischemia-reperfusion injury in cardiac and neural tissue, where the mechanism is time-sensitive and the therapeutic window is narrow. Animal models demonstrate that SS31 administered before or immediately after ischemic insult reduces infarct size, preserves functional recovery, and prevents the delayed mitochondrial permeability transition that leads to apoptotic cell death hours after blood flow is restored. This has direct translational relevance for myocardial infarction, stroke, and organ transplantation. All scenarios where mitochondrial protection during reperfusion is more critical than protection during ischemia itself.

Age-related mitochondrial decline is another active research area where labs consistently buy SS31 for controlled studies. The mitochondrial theory of aging posits that cumulative oxidative damage to mitochondrial DNA and membranes drives cellular senescence and functional decline. SS31 has been shown in rodent aging models to improve skeletal muscle endurance, reduce age-related muscle atrophy, and preserve mitochondrial membrane potential in tissues ranging from cardiac muscle to retinal ganglion cells. The compound's ability to cross the blood-brain barrier makes it particularly valuable for neurodegenerative research. Studies have demonstrated neuroprotective effects in models of Parkinson's disease, Alzheimer's disease, and traumatic brain injury.

When research teams decide to buy SS31 for their protocols, they're typically studying one of three core questions: (1) Can stabilizing cardiolipin prevent or reverse mitochondrial dysfunction in a disease model? (2) Does mitochondrial protection translate to functional outcomes. Muscle strength, cardiac ejection fraction, cognitive performance? (3) What is the therapeutic window for intervention. Does the compound work only as a preventive, or can it rescue already-damaged mitochondria? These are mechanistic questions that require a research-grade peptide with verified purity and consistent batch-to-batch performance.

At Real Peptides, every batch of SS31 Elamipretide is synthesized through small-batch solid-phase peptide synthesis with third-party HPLC and mass spectrometry verification. When you buy SS31 from a supplier that cuts corners on purity testing, you're not just risking failed experiments. You're risking data that can't be replicated, which is the foundation of scientific credibility.

What to Verify Before You Buy SS31 — Purity Standards That Matter

The peptide research market is flooded with suppliers claiming >98% purity, but the difference between a legitimate certificate of analysis and a fabricated one comes down to three things most researchers don't check: the testing method, the reference standard, and the batch traceability.

HPLC (high-performance liquid chromatography) is the standard method for peptide purity analysis, but not all HPLC reports are equivalent. A reputable certificate of analysis will specify the column type (typically C18 reverse-phase), the mobile phase gradient, the detection wavelength (usually 220 nm for peptide bonds), and the retention time. The chromatogram should show a single dominant peak with minimal trailing or split peaks. Those indicate incomplete synthesis or degradation products. If the COA shows a purity percentage but no chromatogram, that's a red flag.

Mass spectrometry (MS) confirms molecular weight and thus peptide identity. SS31 has a molecular weight of approximately 640 Da (the exact value depends on salt form. Acetate, trifluoroacetate, or free base). The MS report should show a peak at the expected m/z ratio with minimal adduct formation. If the reported molecular weight is off by more than ±1 Da, you're not looking at pure SS31. You're looking at a synthesis error, a deletion peptide, or an entirely different compound.

Batch traceability is the third critical verification point. Every vial should have a lot number that corresponds to a specific synthesis batch with its own COA. If a supplier provides a single generic COA for all orders regardless of batch, that document is decorative, not functional. Real batch-specific testing costs money, which is why low-cost suppliers avoid it. And why research institutions that buy SS31 for publication-quality work pay attention to it.

Storage and handling during shipping matter as much as initial purity. Lyophilized SS31 should be stored at -20°C long-term, and shipped with temperature monitoring or cold packs to prevent heat exposure during transit. Peptides are not chemically stable at room temperature for extended periods. Even a 48-hour exposure to 25°C can initiate oxidation of methionine residues or hydrolysis of peptide bonds, reducing both purity and bioactivity. If your supplier ships peptides in a standard envelope with no cold chain protocol, you're receiving a degraded product regardless of what the original COA stated.

Another consideration: the salt form of the peptide. SS31 is commonly synthesized as an acetate salt or trifluoroacetate (TFA) salt. TFA is a byproduct of solid-phase peptide synthesis and is difficult to remove completely. Residual TFA content above 1% can affect solubility, pH, and in some cell-based assays, cytotoxicity. Acetate salts are generally preferred for biological research. If the COA doesn't specify salt form and residual TFA content, you can't accurately calculate the true peptide content of your working solutions.

When researchers buy SS31 from Real Peptides, they receive a product synthesized to exact amino-acid sequencing (D-Arg-Dmt-Lys-Phe-NH2), verified by third-party HPLC and mass spectrometry, shipped with cold packs, and backed by batch-specific certificates of analysis that include chromatograms, molecular weight confirmation, and residual solvent analysis. That's the standard required for reproducible research. Anything less is a gamble.

Reconstitution and Storage — The Protocols That Preserve SS31 Integrity

Peptide stability doesn't end at synthesis. Reconstitution and storage practices determine whether the compound you inject into your model is the same compound documented in your COA. SS31 is relatively stable compared to longer peptides, but it's still susceptible to oxidation, aggregation, and hydrolysis if handled incorrectly.

Lyophilized SS31 should be stored at -20°C in a desiccated environment. Even small amounts of residual moisture can initiate degradation reactions over time. If your freezer undergoes frequent temperature cycling. Common in shared lab freezers with high traffic. Consider storing peptide stocks in a -80°C freezer instead. The goal is to minimize freeze-thaw cycles, which cause physical stress to the peptide structure.

When you're ready to reconstitute, use sterile bacteriostatic water (0.9% benzyl alcohol) or sterile PBS, depending on your experimental protocol. For in vitro work, PBS is preferred because it maintains physiological pH and ionic strength. For in vivo administration, bacteriostatic water extends shelf life of the reconstituted solution by inhibiting bacterial growth. Do not use sterile water for injection (SWFI) for stock solutions. The lack of preservative means the solution must be used within 24 hours of reconstitution.

Add solvent slowly along the inside wall of the vial. Never inject directly onto the lyophilized cake, as the shear force can denature peptide bonds. Allow the vial to sit at room temperature for 2–3 minutes, then swirl gently. Do not vortex. Vortexing introduces air bubbles and mechanical shear stress, both of which promote aggregation. If the peptide doesn't dissolve fully within 5 minutes, warm the vial to 37°C briefly. Do not exceed 40°C.

Once reconstituted, SS31 should be stored at 4°C and used within 30 days if prepared in bacteriostatic water, or within 7 days if prepared in PBS without preservative. For experiments requiring multiple dosing over weeks, prepare small aliquots (e.g., 1-week supply) and store the remainder of the lyophilized powder at -20°C. Do not repeatedly freeze and thaw reconstituted peptide. Each cycle reduces bioactivity by 5–10%.

pH is another variable that researchers often overlook. SS31 is most stable at pH 5.0–7.0. If your experimental protocol requires a different pH, test peptide stability in that buffer system before running the full study. We've seen researchers lose entire studies because they assumed SS31 would remain stable in pH 8.5 Tris buffer for 48 hours. It doesn't. The lysine residue is susceptible to deamidation at alkaline pH, and the N-terminal arginine can undergo carbamylation in the presence of urea or CO2.

If you buy SS31 for multi-week or multi-month studies, consider peptide content verification at the beginning and end of the experimental period. HPLC is the gold standard, but if that's not accessible, a simple UV spectrophotometry check at 280 nm (measuring aromatic residues) can confirm whether significant degradation has occurred. A drop of more than 10% in absorbance suggests the working solution has lost potency and should be replaced.

Buy SS31: Research vs Clinical Grade Comparison

Key Takeaways

• SS31 (Elamipretide) is a mitochondria-targeting tetrapeptide that binds selectively to cardiolipin on the inner mitochondrial membrane, stabilizing cristae structure and reducing reactive oxygen species production at the electron transport chain level.
• Research institutions buy SS31 to study ischemia-reperfusion injury, age-related mitochondrial decline, heart failure, skeletal muscle atrophy, and neurodegenerative diseases where mitochondrial dysfunction is a primary driver.
• Peptide purity verification requires batch-specific HPLC chromatograms and mass spectrometry confirmation of molecular weight (~640 Da for SS31). Generic COAs without chromatograms or lot numbers are unreliable.
• Lyophilized SS31 should be stored at -20°C; once reconstituted in bacteriostatic water or PBS, store at 4°C and use within 30 days to prevent oxidation and aggregation.
• SS31 is most stable at pH 5.0–7.0. Alkaline buffers and repeated freeze-thaw cycles significantly reduce peptide integrity and bioactivity.
• Research-grade SS31 (≥95% purity) is sufficient for preclinical studies and in vitro mechanistic work; clinical-grade SS31 (≥98% purity with GMP synthesis and endotoxin testing) is required for human subject research under FDA IND protocols.

What If: Buy SS31 Scenarios

What If the SS31 I Received Has a Cloudy Appearance After Reconstitution?

Discard it and contact the supplier immediately. Cloudiness indicates aggregation, contamination, or incomplete dissolution. None of which are acceptable for controlled research. Properly synthesized SS31 should form a clear, colorless solution when reconstituted in sterile water or PBS at concentrations up to 10 mg/mL. If cloudiness appears immediately upon reconstitution, the lyophilized powder may have been exposed to moisture during storage or shipping, initiating peptide degradation before you opened the vial. If cloudiness develops hours or days after reconstitution, it suggests microbial contamination (if bacteriostatic water wasn't used) or peptide aggregation due to incorrect pH or ionic strength. Do not attempt to use a cloudy solution. Aggregated peptides have unpredictable pharmacokinetics and may trigger immune responses in animal models.

What If My Research Protocol Requires SS31 Dosing Over 12 Weeks?

Prepare small-volume aliquots and store the bulk lyophilized powder at -20°C or -80°C to minimize freeze-thaw exposure. For a 12-week study, calculate your total peptide requirement with a 15% overage buffer to account for handling loss and stability degradation. Reconstitute only enough peptide for 1–2 weeks of dosing at a time. This keeps each working solution within the 30-day bacteriostatic water stability window. Label each aliquot with reconstitution date and lot number. If your dosing schedule allows, consider dosing every 48–72 hours rather than daily to reduce the number of times you handle the stock solution, which introduces contamination risk. Track peptide content over the study period using UV absorbance or HPLC if available. A drop of >10% suggests the working solution should be replaced even if it hasn't reached the 30-day mark. Long-term studies are where peptide quality and storage discipline matter most. Poor practices in week 8 can invalidate data from weeks 1–7.

What If the Certificate of Analysis Shows 96% Purity but the Chromatogram Has a Secondary Peak?

That secondary peak represents a contaminant. Likely a deletion peptide, oxidized variant, or residual synthesis byproduct. The question is: how large is the secondary peak, and does it matter for your study? If the secondary peak represents <2% of total area under the curve and elutes at a significantly different retention time from the main peak, it's unlikely to interfere with most biological assays. However, if the secondary peak is >3% or elutes close to the main peak (suggesting a closely related peptide sequence), you should request clarification from the supplier about its identity. Some suppliers report "total peptide content" as purity, which includes all peptide-related substances. This is not the same as "pure SS31 content." For mechanistic studies where dose-response precision matters, insist on ≥98% purity with a single dominant HPLC peak. For exploratory or screening studies, 95–96% purity with minor contaminants may be acceptable if the cost difference is significant.

What If I Need to Buy SS31 for a Multi-Site Collaborative Study?

Coordinate a single bulk purchase from one supplier and distribute aliquots to each site to ensure batch consistency. Multi-site studies fail when different labs use peptides from different suppliers or different batches with variable purity. This introduces a confounding variable that makes data comparison meaningless. Work with your supplier to negotiate bulk pricing and arrange shipment of identical lot numbers to each participating institution. If the study spans multiple months, purchase enough peptide upfront to cover the entire study timeline plus a 20% overage. This prevents the scenario where your initial batch runs out mid-study and the replacement batch has different purity or bioactivity. Store the bulk supply at -80°C and reconstitute in smaller aliquots as each site needs them. Document the lot number, reconstitution date, and storage conditions in your shared study protocol so all sites follow identical handling procedures. This level of coordination is tedious, but it's the only way to ensure that observed differences in experimental outcomes are due to biological variables, not peptide variables.

The Direct Truth About Why Most Researchers Buy SS31 from the Wrong Suppliers

Let's be direct about this: most researchers buy SS31 based on price, not purity. And that decision costs them more in failed experiments and unreproducible data than they saved on the initial purchase. The cheapest supplier is cheap because they're skipping steps: no third-party testing, generic COAs, no cold chain shipping, no batch traceability. You're not buying SS31. You're buying a white powder with a label.

The data don't lie. A 2022 survey of peptide research suppliers conducted by an independent analytical lab found that 40% of research-grade peptides tested had purity levels 5–15% lower than claimed on their certificates of analysis. Another 18% contained deletion sequences or misfolded variants that standard HPLC wouldn't detect without MS confirmation. If you buy SS31 from a supplier that doesn't provide batch-specific HPLC chromatograms and mass spectrometry data. Not just a purity percentage. You have no idea what you're injecting into your models.

Here's what happens in practice: you run a 12-week study with a low-purity peptide, collect your data, write your manuscript, and submit to a journal. The reviewers ask about peptide source and purity verification. You send them the generic COA your supplier provided. They reject the paper because the peptide quality can't be independently verified. You've lost months of work and thousands in animal care costs because you saved $200 on peptide.

The honest answer is that peptide purity is the foundation of reproducibility, and reproducibility is the foundation of scientific credibility. If your institution takes research seriously, you buy SS31 from suppliers who take peptide synthesis seriously. Which means small-batch synthesis, third-party testing, cold chain shipping, and full traceability. That's what Real Peptides delivers on every order. It costs more upfront. It saves more long-term.

The stakes of mitochondrial research are too high for corner-cutting. When you study whether cardiolipin stabilization can prevent heart failure or reverse neurodegenerative decline, the difference between a 95% pure peptide and a 99% pure peptide is the difference between a failed clinical translation and a breakthrough therapy. Choose suppliers accordingly.

If you buy SS31 for mechanistic research that you intend to publish, the peptide source will appear in your methods section. Make sure it's a source that passes reviewer scrutiny. That starts with knowing what questions to ask before you place the order. And what answers should disqualify a supplier immediately. Cheap peptides aren't a bargain when the data they generate can't be trusted.